by editor | Feb 22, 2013 | Clinicians, Participants
John McNeil discusses publicity of aspirin studies with the Australian Ageing Agenda ASPREE Principal Investigator, Professor John McNeil spoke to the Australian Ageing Agenda about the ASPREE study and the mixed messages about aspirin in the media....
by editor | Jan 31, 2013 | Clinicians, Participants
ASPREE and leading AMD researcher pens open letter to participants Dear ASPREE participants and interested parties, Recently you may have heard press reports that suggested aspirin might worsen an infrequent type of the eye disease called age – related macular...
by editor | Jan 23, 2013 | Clinicians, Participants, Researchers
Authors of aspirin and AMD paper say study lacks robustness to change clinical practice ANNOUNCEMENT Melbourne, January 23 2013 – Professor John McNeil, Head of Monash University’s Department of Epidemiology and Preventive Medicine and Lead Investigator of the...
by editor | Oct 30, 2012 | Clinicians, Participants, Researchers
Aspirin may block the growth of colorectal tumours with a specific genetic mutation Researchers affiliated with the Harvard Medical School reported that aspirin was associated with a prolonged life of patients with tumours that carried the mutated PIK3CA gene –...
by editor | Oct 15, 2012 | Clinicians, Participants, Researchers
Further support for a randomised clinical trial of aspirin, Oncologist says New research published in Acta Obstetricia et Gynecologica Scandinavica, a journal of the Nordic Federation of Societies of Obstetrics and Gynecology, showed regular aspirin may...
Recent Comments